Burton R C, Warner N L
Br J Cancer. 1978 Feb;37(2):159-70. doi: 10.1038/bjc.1978.24.
Two 3-methylcholanthrene and a spontaneous BALB/c fibrosarcoma were examined for tumour-associated antigens (TAA) by in vivo and in vitro induction of tumour-immune responses. When BALB/c mice were immunized to these fibrosarcomas by surgical tumour removal, cross-reacting tumour-associated transplantation antigens (TATA) were detected on all 3 tumours. Cytotoxic effector cells (CL) were then induced in vitro by co-culture of BALB/c spleen cells with the spontaneous, or one of the carcinogen-induced fibrosarcomas. These CL were shown to be cytotoxic T cells (Tc) and to be directed against cross-reacting TAA on all 3 tumours, by two in vitro 51Cr-release assay systems, direct 51Cr-release cytotoxicity and cellular competitive inhibition of 51Cr release. Further studies demonstrated that the fibrosarcoma TAA involved in in vitro induction of Tc were not present on normal adult or foetal tissues. A secondary cytotoxic response was also detected in vitro when spleen cells from mice immunized to a carcinogen-induced fibrosarcoma were tested. The patterns of cross-reactivity detected by the in vivo and primary in vitro tumour-immune responses suggested that the TAA detected in vivo (TATA) were not identical to the TAA detected in vitro.
通过体内和体外诱导肿瘤免疫反应,对两个3-甲基胆蒽诱导的肿瘤和一个自发的BALB/c纤维肉瘤进行了肿瘤相关抗原(TAA)检测。当通过手术切除肿瘤使BALB/c小鼠对这些纤维肉瘤产生免疫时,在所有3个肿瘤上均检测到了交叉反应性肿瘤相关移植抗原(TATA)。然后,通过将BALB/c脾细胞与自发的或一种致癌物诱导的纤维肉瘤共同培养,在体外诱导出细胞毒性效应细胞(CL)。通过两种体外51Cr释放测定系统,即直接51Cr释放细胞毒性和51Cr释放的细胞竞争抑制,证明这些CL是细胞毒性T细胞(Tc),并且针对所有3个肿瘤上的交叉反应性TAA。进一步的研究表明,参与体外诱导Tc的纤维肉瘤TAA在正常成年或胎儿组织中不存在。当检测来自对致癌物诱导的纤维肉瘤产生免疫的小鼠的脾细胞时,在体外也检测到了二次细胞毒性反应。体内和初次体外肿瘤免疫反应检测到的交叉反应模式表明,体内检测到的TAA(TATA)与体外检测到的TAA不同。